[Achromobacter xylosoxidans bacteremia in a patient with community-acquired pneumonia].
Achromobacter xylosoxidans is a rare cause of bacteremia, and little information on treatment is available. The majority of patients who have developed Achromobacter bacteremia have presented predisposing causes to the infection. A case of community-acquired pneumonia and bacteremia due to A. xylosoxidans in a previously healthy patient is reported. Achromobacter is usually resistant to ampicillin, cephalosporins (1st, 2nd, and 3rd generation), aminoglycosides, and fluoroquinolones. Piperacillin, piperacillin-tazobactam, and trimethoprim-sulfamethoxazole inhibit most isolates.
de Fernández
M I
MI
Servicio de Microbiología, Instituto Argentino de Diagnóstico y Tratamiento, Buenos Aires, Argentina. migf@infovia.com.ar
Bugarín
G
G
Arévalo
C E
CE
D000368:Aged; D000369:Aged, 80 and over; D000421:Alcaligenes / Q000187:drug effects / Q000302:isolation & purification*; D016470:Bacteremia / Q000175:diagnosis / Q000382:microbiology*; D017714:Community-Acquired Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D016905:Gram-Negative Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D008297:Male; D018410:Pneumonia, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*